ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Church & Dwight and Procter and Gamble side by side

Their registered studies and the programs behind them, as ClinicalTrials.gov shows them and the companies' own pipelines name them. Counts, not rankings: the companies differ in size, so each number is shown beside its share of that company's own programs.

At a glance

Studies each sponsor leads, with the companies grouped under it. Every number opens the studies it counts.

Church & DwightProcter and Gamble
studies on the registry3885
open to participants now00
phase 3 studies under way00
reach primary completion within a year00
programswith a study of their own in two years48

Pipeline by phase

Each program once, at the furthest phase its own studies reached. The bar is the share of that company's programs, so a small company and a large one read on the same scale.

Furthest phaseChurch & DwightProcter and Gamble
Phase 1

Church & Dwight: 4 of its 4 programs at phase 1

  1. Tin Fluoridesno phase
  2. Test toothpasteno phase
  3. Active Comparator Fluoride Treatment (0.454% SnF)no phase
  4. Toothpasteno phase
100%
00%
Phase 200%

Procter and Gamble: 1 of its 8 programs at phase 2

  1. Sodium Fluoridephase 2
13%
Phase 300%00%
Approved, new studies00%

Procter and Gamble: 7 of its 8 programs at approved, new studies

  1. Tin Fluoridesapproved, new study
  2. 0 ppm Fapproved, new study
  3. 1100 ppm as MFPapproved, new study
  4. 250 ppm F as MFPapproved, new study
  5. 2800 ppm F as MFPapproved, new study

and 2 more — sign in to see them all

88%

Readouts ahead

Programs whose next study reaches primary completion in each month, by the sponsor's own estimate. A ring marks a month with a phase 3 readout.

Nov ’26DecJan ’27FebMarAprMayJunJulAugSepOct
Church & Dwight0 readouts · 0 phase 3············
Procter and Gamble0 readouts · 0 phase 3············
size: programs that monthincludes phase 3Dates are estimates the sponsors file and often move.

Changed in the last 90 days

Since Aug 23, 2026: programs whose first study was registered, programs that reached a new phase, studies stopped, and primary completions moved later (a month or more in phase 3, three otherwise). Stops and dates are read from the registry’s changes, kept since Sep 25, 2026.

Church & Dwight

New programs 0

None

Reached a new phase 0

None

Study stopped 0

None

Primary completion later 0

None

Procter and Gamble

New programs 0

None

Reached a new phase 0

None

Study stopped 0

None

Primary completion later 0

None

Where they overlap

Conditions where at least two of them have programs: 5 in all. A program counts in each condition its studies name most.

ConditionChurch & DwightProcter and Gamble
Gingivitisboth · compare here

Church & Dwight in Gingivitis: 2 programs

  1. Tin Fluoridesno phase
  2. Toothpasteno phase

Their studies: Church & Dwight’s studies of Gingivitis in search

Procter and Gamble in Gingivitis: 4 programs

  1. Sodium Fluoridephase 2
  2. Tin Fluoridesapproved, new study
  3. Cetylpyridiniumapproved, new study
  4. Test Stannous Fluoride Dentifriceapproved, new study

Their studies: Procter and Gamble’s studies of Gingivitis in search

Dental Plaqueboth · compare here

Church & Dwight in Dental Plaque: 1 program

  1. Tin Fluoridesno phase

Their studies: Church & Dwight’s studies of Dental Plaque in search

Procter and Gamble in Dental Plaque: 3 programs

  1. Sodium Fluoridephase 2
  2. Tin Fluoridesapproved, new study
  3. Cetylpyridiniumapproved, new study

Their studies: Procter and Gamble’s studies of Dental Plaque in search

Dentin Sensitivityboth · compare here

Church & Dwight in Dentin Sensitivity: 1 program

  1. Tin Fluoridesno phase

Their studies: Church & Dwight’s studies of Dentin Sensitivity in search

Procter and Gamble in Dentin Sensitivity: 2 programs

  1. Sodium Fluoridephase 2
  2. Tin Fluoridesapproved, new study

Their studies: Procter and Gamble’s studies of Dentin Sensitivity in search

Diabetes Mellitus, Type 2both · compare here

Church & Dwight in Diabetes Mellitus, Type 2: 1 program

  1. Tin Fluoridesno phase

Their studies: Church & Dwight’s studies of Diabetes Mellitus, Type 2 in search

Procter and Gamble in Diabetes Mellitus, Type 2: 2 programs

  1. Tin Fluoridesapproved, new study
  2. Cetylpyridiniumapproved, new study

Their studies: Procter and Gamble’s studies of Diabetes Mellitus, Type 2 in search

Halitosisboth · compare here

Church & Dwight in Halitosis: 1 program

  1. Tin Fluoridesno phase

Their studies: Church & Dwight’s studies of Halitosis in search

Procter and Gamble in Halitosis: 1 program

  1. Tin Fluoridesapproved, new study

Their studies: Procter and Gamble’s studies of Halitosis in search

Same targetBetaPro · free during the beta

Programs that act on the same gene, from the company’s own words, a judged reading of NCIt, ChEMBL or the studies, or a rule. A reading by rule is marked rule.

No gene two of them both target, among the programs whose target is known.

A target, or a pathogen for a vaccine, known for: Church & Dwight 0 of 4 · Procter and Gamble 0 of 8 programs. Most early programs are named only by a code and their companies do not say what they act on, so this list is short and grows as targets are read.

What this can't show

  • Only what ClinicalTrials.gov holds: programs run only in other registries are missing.
  • Grouping is ours: subsidiaries and acquisitions counted under the parent, each dated and sourced on the sponsor page.
  • Readout dates are the sponsors’ estimates, not results.
  • A program is a drug as the registry names it: a code its company has not tied to a name counts on its own until it is read, and a study run under a partner’s name counts for the partner.
  • “Same target” covers only the programs whose target is known, from the company’s words, a judged reading or a rule; most early programs say nothing of it.